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STUDIES IN MICROENCAPSULATION OF RODENTICIDES
P. B. CORNWELL, Director of Research, Rentokil Laboratories Ltd., Felcourt, E. Grinstead,
Sussex, England

ABSTRACT: Warfarin, zinc phosphide, norbormide and alphachloralose have been microencapsulated
by the technique of coacervation and fed to laboratory rats (R. norvegicus) and mice (M.
musculus). Results are given of experiments in which the concentration of rodenticide, wall
material and phase ratio have been varied separately and in combination. Experiments are also
reported in which normal and encapsulated rodenticide has been fed together in the same test
diet.
Microencapsulation can increase the intake of rodenticides, appreciably, whether or not
alternative food is simultaneously available. Nevertheless, significantly higher k i l l s from
higher intakes of poison have not been achieved, indicating difficulties in optimising the
characteristics of the capsule wall to achieve the desired release of ingested active ingredient.
INTRODUCTION
Microencapsulation can be defined as a chemical process by which minute amounts of solids
or l i q u i d s are enclosed w i t h i n a thin wall of suitable material to prevent their reaction with
some component of the environment. The properties of the wall are so designed to keep the
reactive materials apart until they are required to mix.
Microencapsulation, as an industrial process, has been developed for many applications by
the National Cash Register Co. These include carbonless copying paper, drugs with designed
release characteristics, as well as uses in the perfumery, adhesive and food industries
(Gordon, 1965). The costs vary from 40 U.S. cents to $4 per kg. of encapsulated material
(Watson, 1970) and many future applications have been proposed.
The use of t h i s technique for the improvement of pest control chemicals has yet to be
exploited. In 1948, Ripper et al._ postulated that if individual particles of a toxic compound
could be coated with a substance digestible only by certain insects, specificity of action
might be achieved. Subsequent tests on plants sprayed with particles of DDT, coated with
degraded cellulose, showed that contact action against non-phytophagous insects had been
eliminated, whereas plant-eating species succumbed.
Reviewing the possible uses of microencapsulation for improving crop sprays, P h i l l i p s
(1968) l i s t s the advantages: reducing the repellency of insecticides, protecting pesticides
from degradation by weather and reducing the need for protective clothing. Studies have also
been carried out into the encapsulation of bacteria (Raun & Jackson, 1366): by t h i s means it
would seem possible to extend the field activity of Bacillus thuringiensls without loss in
efficacy against European corn borer (Ostrinia n u b i l a l i s ) .
Microencapsulation has been proposed as a technique for improving the efficiency of
rodenticides: by preventing contact of the poison with the chemoreceptors of the rodent
palate it may be possible to increase the intake of unpalatable poisons. At the same time, it
would appear advantageous to design the properties of the coating material to cause the
release of the internal phase (the rodenticide) at the right time and in the right quantity to
increase k i l l .
As far as is known, the first study into the encapsulation of rodenticides was undertaken
by Shuyler (U.S. Patent 2,957,804 of 1960). Arsenic and strychnine were prepared as entericcoated "micro-pills", but f i e l d t r i a l s indicated that some were inadequately coated or
partially lacking in enteric coat (personal communication). Subsequently, Greaves et al.
(1968) reported laboratory tests showing apparently improved k i l l from bait feeding tests with
encapsulated norbormide and alphachloralose.
The purpose of t h i s paper is to summarise some of the investigations into microencapsulation of rodenticides carried out at this laboratory. About 150 batches of encapsulated
rodenticide have been prepared and a high proportion of these fed in baits to rats and mice.
Studies have been made to improve the action of warfarin, zinc phosphide, norbormide and
alphachloralose. Most have resulted in improved intake of active ingredient, but only rarely
have they resulted in improved k i l l beyond the biological variation recognised to exist in
groups of laboratory animals.
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THE ENCAPSULATION PROCESS
Of the many methods of making microcapsules, the best known is coacervation, which was
used exclusively in preparing test samples for the present work. In principle, the rodenticide
to be encapsulated is dispersed and kept suspended in a l i q u i d in which the active ingredient
must be insoluble. A third material to provide the capsule wall (e.g., gelatin/gum arabic, or
ethyl cellulose) is contained in the medium. By varying the temperature, pH, or addition of
other material (e.g. carrageenan), the wall material is made insoluble (coacervation) and forms
a continuous wall around the suspended particles. The ratio of internal to external phase (the
phase ratio) can be modified w i t h i n broad l i m i t s by varying the amounts of the various
components in the system. Low phase ratios result in thicker walls being formed than high
ratios. The size of encapsulated particles can be varied according to the uniformity of
dispersion and the control exercised at the stage of coacervation. Particles encapsulated in
gelatin are then usually hardened.
Spherical particles can be more easily and uniformly coated than elongate crystals. In
the latter case, the wall is variable in thickness and the active particles are more l i k e l y
to be encapsulated as aggregates rather than as discrete crystals.
THE RODENTICIDES STUDIED
Warfarin at the recommended concentrations for incorporation into baits (0.005 - 0.05%) is
readily taken in the presence of alternative food by rats (R. norveglcus) and to a lesser
extent by mice (M_. musculus). Because of the increasing spread of resistance to warfarin in the
U.K. by both species, leading to survival at the recommended levels, encapsulation was
examined as a means of increasing the acceptance by rodents of high concentrations which would
normally be rejected.
Zinc phosphide suffers from the defect of most acute poisons, that inadequate take of
b a i t at the i n i t i a l feed and the subsequent onset of symptoms of poisoning lead to discrimination against baits (bait shyness). As a result, prebaiting is recognised as a prerequisite
for good rat control although t h i s may not be necessary with zinc phosphide against mice.
The potential advantages of microencapsulation - taste masking and delaying the onset of
symptoms - could therefore lead to an improvement in properties of zinc phosphide when used at
the recommended concentration. It should be noted that t h i s rodenticide has a density of 4.6
which causes problems in achieving good dispersion of particles during coacervation.
Norbormide (R)* offers selective action against Rattus spp. but also suffers from the
defect of too rapid onset of poisoning symptoms. Detoxification of norbormide is f a i r l y
rapid, and sublethal doses lead to bait discrimination. Norbormide was encapsulated to
increase bait intake and delay onset of symptoms but it is not easy to encapsulate t h i s
rodenticide in small discrete particles.
Alphachloralose, at a concentration of 4%, was introduced in the U.K. for mouse control in
1964. This compound interferes with thermo-regulation and is more effective at temperatures
below 60°F, than above. The small body si z e of the mouse, with i t s h i g h surface area to
volume ratio, confers a considerable degree of specificity resulting in minimal hazard to
domestic animals. Under favourable conditions, poisoning symptoms (ataxia) occur in mice in 510 minutes, and feeding usually ceases w i t h i n 20 minutes, often leading to inadequate b a i t
intake. Detoxification is also rapid leading to recovery in 6-8 hours. This rodenticide has
a long t h i n crystal, least favourable to the production of uniform wall thickness during
encapsulation.
DESIGN OF THE EXPERIMENTS
Albino mice (2O-3Og) and Wistar Albino rats (3OO-35Og) were caged i n d i v i d u a l l y or in
groups, with equal numbers of each sex. Rodenticides were formulated in 90% medium oatmeal
and 10% sugar. In some tests, alternative food was provided at the same time as the poison,
depending on the purpose of the experiment, the diets being alternated in position to avoid
place preference. A v a i l a b i l i t y of the test diet was in most cases l i m i t e d to short periods, to
reduce the influence of k i l l on bait intake.
* The active ingredient of Raticate.

Comparisons were made in a l l tests with unencapsulated poison,
investigated, separately and in combination:
1.
2.
3.

Three variables were

rodenticide concentration.
phase ratio (thickness of capsule wall).
composition of the capsule wall.

Examples are also given of experiments in which normal and encapsulated rodenticides were
combined together in different proportions in test diets.
RESULTS
1. Varying the concentration of active ingredient.
a) Warfarin.
Examples of studies on rodenticide concentration, with and without microencapsulation,
are given by two experiments with warfarin. The f i r s t , in which warfarin encapsulated in
ethyl cellulose (at 6:1) was fed to rats at three concentrations (0.005%, 0.05% and 0.5%),
with a choice of unencapsulated warfarin, and the second in which these same concentrations of
both encapsulated and normal warfarin were fed with unpoisoned food as a choice.
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Fig. I. D a i l y intake (g.) of diets containing normal and microencapsulated
warfarin (ethyl cellulose 6:1) fed as a choice at three concentrations to rats (8 per treatment) for four days;
Low concentrations of warfarin (0.005%) are readily taken by rats and l i t t l e improvement in acceptance from encapsulation is to be expected (Fig. Ia). With higher concentrations (0.05%), a small but consistently higher intake of encapsulated warfarin was obtained
throughout the four-day feed (Fig. Ib). At the highest concentration (0.5%) which is
markedly less palatable, encapsulation afforded a striking increase in bait intake (Fig. Ic).
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Fig. I I .

Intake (g/rat) of diets containing normal and microencapsuiated
warfarin (ethyl cellulose 6:1), fed at three concentrations to
rats (8 per treatment) for four days with alternative food. K i l l
at two weeks.

When encapsulated warfarin was fed with unpoisoned food as the choice, only at the
highest concentration (0.5%) did encapsulation markedly improve intake of the poison (Fig.
I I ) . but failed to increase mortality.
b)

Zinc phosphide.

This acute rodenticide is far less acceptable to rats and mice than warfarin, even at
concentrations well below the 4% normally used for rodent control. Taste masking could
therefore provide a considerable advantage. When three concentrations (1%, 2% and 4%) of
normal and encapsulated zinc phosphide (4:1 in ethyl cellulose) were fed to mice with alternative food, a s i m i l a r 2-3 fold increase in intake was obtained by encapsulation, at a l l
three concentrations and throughout the four-day feed (Fig. I I I a ) . Nevertheless, t h i s
higher intake of active ingredient failed to increase mortality above that obtained with
unencapsulated zinc phosphide (Fig. IIIb).
2. Varying the phase ratio.
The experiments described in the previous section suggest that insufficient active
ingredient was released through the wall coating to improve k i l l , or that it was not released sufficiently early in its passage through the gut to be adequately absorbed. An
example of experiments to study the effects of different phase ratios of ethyl cellulose
capsules, to improve release, is given by a test in which a very high concentration of
alphachloralose (12%) was fed to batches of 16 mice for 24 hours at high temperature. The
poison baits were then removed and alternative food provided.
In this test, a two-fold increase in intake of active ingredient was obtained with
encapsulation at ratios of 20:1, 15:1 and 10:1 and a three-fold increase at 4:1 (Fig. IV).
Measurements of symptom expression, scored on an arbitrary scale of five points ranging
between normality and death, showed that a maximum was reached 1 hour after the beginning
of feeding with normal alphachloralose and with encapsulation at 20:1. At 4 hours, maximum
symptoms were obtained with 15 and 20:1, but by 24 and 48 hours, recovery was complete in
almost a l l mice except a few showing symptoms, notably those fed at ratios 4:1 and 10:1.
This indicates somewhat different release characteristics of alphachloralose with capsules
of varying internal:external phase, but again, in no case was there a significant improvement in k i l l despite the higher intakes of active ingredient.
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Fig. I I I . Diets containing normal and microencapsulated zinc phosphide
(ethyl cellulose 4:1) fed at 1, 2 and $% to mice (24 per treatment) for
four days with alternative food.
a)

intake (g/mouse) after 1 and 4 days.

b)

accumulated k i l l on diets containing 1 and 4%.

Fig. IV.

3.

Intake (g/mouse) of diets containing normal and microencapsulated
alphachloralose, at various phase ratios, fed at 12% to mice (16 per
treatment) at 72-75°F for 24 hours, followed by alternative food. Also
symptom expression (%) and k i l l at 48 hours.

Varying the phase ratio and wall material.

Improvements in the palatability and k i l l which might be obtained from microencapsulation depend on optimising the release characteristics of the wall material. Gelatin and
ethyl cellulose are both suitable for the encapsulation of rodenticides, but gelatin w a l l s
are modified by combination with gum arabic or carrageenan; ethyl cellulose is not modified
by encapsulation as a hot or cold process but can be influenced by the use of various waxes,
to improve uniformity of coating and to reduce wall permeability.
a)

Gelatin and ethyl cellulose at low phase ratios.

Results for batches of 12 rats fed for 1 day on 0.25% and 0.5% norbormide, encapsulated
in various systems, f a i l e d to give any striking improvement in k i l l over unencapsulated
norbormide. Instead, a consistent loss in rodenticidal activity was obtained with a l l wall
coatings at phase ratios of 4:1 and below (Fig. V). At these low ratios, ethyl cellulose
coatings provided lower k i l l s than gelatin systems.
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KILL
AFTER
1 DAY

ENCAPSULATED
Fig. V.

Fig. V I.

NORMAL

Mortality of rats fed diets containing 0.25% and 0.5% norbormide
(normal and encapsulated in various systems) fed for one day
without alternative food. (24 rats per treatment).

Palatability ratio (poison : alternative food) of diets containing
0.5% norbormide (normal and microencapsulated in ethyl cellulose
and gelatin at various phase ratios) fed to rats (30 per treatment)
for 3 days with alternative food. Also k i l l (%) at 3 days.
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b)

Gelatin and ethyl cellulose at high phase ratios.

Examples of tests to evaluate walls of gelatin and ethyl cellulose at high ratios is
again given for rats fed 0.5% encapsulated norbormide. In t h i s case they were fed for 3
days with alternative food (Fig. VI). In 8 treatments out of 9, w a l l s of both materials
increased the ratio of intake of poison to the alternative food compared with unencapsulated poison. With ethyl cellulose as the wall material, lower k i l l s were obtained with
reducing phase ratios. With gelatin, however, mortality was not greatly modified by phase
ratio and in no treatment was the k i l l different from norbormide per se.
c)

Ethyl cellulose with wax spreaders.

To ensure more uniform encapsulation of the internal phase, waxes can be combined with
ethyl cellulose during the encapsulation process. This also influences wall permeability.
In addition, washing in a suitable solvent (methanol) was carried out, to ensure that no
rodenticide contaminated the outside of the capsule w a l l .

Fig. V I I .

Intake (g/mouse) of diets containing normal and microencapsuiated
alphachloralose (gelatin/carrageenan and ethyl cellulose by hot
process) wax treated and methanol washed, fed to mice (16 per
treatment) at 6l-64°F. for 1 day, followed by alternative food. Also
k i l l at 3 days.

The use of waxes improved the intake of encapsulated alphachloralose (Fig. V I I ) but
apparently further reduced the amount of active ingredient released. The highest k i l l obtained with polawax, subsequently washed in methanol, but t h i s was no greater than the k i l l
obtained with normal alphachloralose.
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4) Varying the phase ratio and concentration.
As early experiments tended to indicate that microencapsulation restricted the availab i l i t y of "released" internal phase, especially at low phase ratios, tests were carried out
to compare the effects of feeding low and high concentrations of encapsulated zinc phosphide
and norbormide. Zinc phosphide was encapsulated in gelatin/carrageenan and norbormide encapsulated in gelatin. Both rodenticides were fed at a number of phase ratios.
a)

Zinc phosphide.

In t h i s experiment the test diets were fed to rats for 1 hour, and only then was alternative food made available. Restricting the test feed to a short period allows a more c r i t i cal evaluation of palatability since symptoms of poisoning do not then interfere with "takes"
in the various treatments.

Fig.V I I I
.

Intake (g/rat) of diets containing 4% and 10% zinc phosphide
(normal and microencapsulated in gelatin/carrageenan, at various
phase ratios) fed to rats (16 per treatment) for one hour. Also
k i l l at 7 and 24 hours.

There were only minor differences in intake of the encapsulated zinc phosphide compared
with the normal, but without any clear indication of improved intake at any phase ratio
(Fig. V I I I ) . The number of rats k i l l e d at the 4:1 ratio was somewhat lower than at higher
ratios, and this occurred at both concentrations. At the higher ratios (8:1 to 20:1) there
were small, but inconsistent improvements in k i l l compared with the unencapsulated poison,
but which were no greater with the higher concentration of zinc phosphide (10%) than with
the lower (4%).
b)

Norbormide.

A further experiment to investigate the interaction of phase ratio and concentration
was the study undertaken on norbormide to obtain confirmation of improved mortality reported
by Greaves et al._ (1968). Gelatin capsules (4:1, 8:1 and 12:1) were fed at four concentrations (0.8%, 1.2%, 1.6% and 3.0%) to groups of 10 rats for three days with alternative food.
A major difference, however, between t h i s test and the work previously reported, was the
much higher k i l l (70-90%) provided by the unencapsulated norbormide, upon which it was hoped
to improve.
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Fig. IX.

Intake (g/rat) of diets containing 0.8, 1.2, 1.6 and 3.0%
norbormide (normal and microencapsulated in gelatin at various
phase ratios) fed to rats (10 per treatment) for 3 days with
alternative food. K i l l at 3 days shown in each histogram (see
also Table I).

Higher intakes of active ingredient were obtained with a l l treatments involving encapsulated norbormide with evidence of a possible interaction between phase ratio and norbormide
concentration (Fig. IX). Summing separately over concentrations and phase ratios the mort a l i t y obtained for each group of rats is shown in Table I. With the possible exception of
diets containing 3% norbormide, encapsulation failed to increase k i l l beyond that obtained
with unencapsulated norbormide.
Table I. Mortalities obtained by feeding diets containing 0.8, 1.2, 1.6 and
3.0% norbormide (normal and microencapsulated in gelatin at phase ratios of
4:1, 8:1 and 12:1) to rats (10 per treatment) for 3 days. (See also Fig. IX).
Summing over concentration.

Encapsulated

Normal

4:1

32/40

8:1

34/40

12:1

33/40
31/40

Summing over phase ratio.
Encapsulated.

Normal,

0.8%

26/30

9/10

1.2%

21/30

9/10

1.6%

24/30

7/10

3.0%

28/30

7/10

5) Combination of normal and encapsulated rodenticides in baits.
Experience in the laboratory and in the f i e l d use of
alphachloralose, shows that a mouse eating t h i s rodenticide exhibits
obvious symptoms of poisoning in 15-30 minutes and becomes unconscious
in 1-2 hours. If a sublethal amount is eaten, recovery occurs within
8 hours and is usually complete within 24 hours. Encapsulated
alphachloralose has s i m i l a r action but onset of symptoms is often
delayed because of the capsule w al l .

Fig.X
.

Possible advantage of combining normal and microencapsulated
rodenticide in baits to obtain extended physiological action.

A "two-hit" system was therefore postulated (Fig. X) in which the level of alphachloralose in the blood might be raised to a high level by unencapsulated alphachloralose, and
t h i s high level maintained by continued release from encapsulated alphachloralose as a
second component. This type of "sustained release" is already being exploited for improving
the action of some pharmaceutical preparations.
Experiments were thus carried out to examine the proportions of normal and encapsulated
alphachloralose required in baits to provide increased kill. Two-component baits incorporat i n g
norbormide were also studied.
a)

Alphachloralose.

In the f i r s t of two experiments, groups of 96 mice were fed a series of diets containing
different proportions of normal and encapsulated alphachloralose totaling 4% active
ingredient. At one end of the series the diet contained 4% normal alphachloralose and at
the other, it contained 4% encapsulated. Encapsulation was carried out in ethyl cellulose
at a phase ratio of 10:1 and the mice fed for 2 days at 5O-59°F. Half the mice (48 per
treatment) were fed with alternative food and the other half without.
The intake of rodenticide progressively increased with the amount of encapsulated
alphachloralose, whether or not alternative food was available (Fig. X I a and XIb). Intake of
the diet containing f u l l y encapsulated poison was 3-5 times higher than that containing only
normal alphachloralose.
Without alternative food (Fig. XIa), kill progressively decreased with increasing proportion of encapsulated poison. In the presence of alternative food, however, some combinations of normal and encapsulated poison (around 50% of each) resulted in kills in excess of
the mortality (23%) obtained with the wholly unencapsulated diet (Fig. XI b) . It should be
noted that t h i s "control" mortality was far lower than in the experiment which follows.

93

Fig. XI.

Diets containing normal and microencapsulated alphachloralose
(10:1 ethyl cellulose) fed in various proportions, at 4%, to
mice (48 per treatment) for 2 days at 5O-59°F .
a)

intake (g/mouse) and k i l l with no alternative food.

b)

same with alternative food.
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Fig. XII. Kill obtained with diets containing normal and microencapsulated
alphachloralose (ethyl cellulose 10:1) fed at various concentrations to mice (28 per treatment), (a) normal alphachloralose
separately, (b) encapsulated alphachloralose separately, (c) in
combination at 4% active ingredient. The bottom graph also shows
the total mortalities obtained by adding (a) plus (b).
A repeat of this experiment (Fig. XII) with identical combinations of encapsulated and
unencapsulated alphachloralose failed however to substantiate this improvement. In this
instance, the mice again had access to alternative food, but the temperature was somewhat
lower (46-54ºF) and mortality on the wholly unencapsulated diet was high (about 30%). As
expected the k i l l of mice fed only normal alphachloralose, progressively decreased with
reducing concentration (Fig. XIIa) and mortality on diets containing encapsulated alphachloralose alone progressively increased with concentration (Fig. XIIb). When normal and
encapsulated alphachloralose was combined in different proportions, but always totaling 4%,
no improvement in kill resulted (Fig. XIIc).
b) Norbormide.
In a final experiment, 0.25% norbormide (normal) with 0.75% norbormide (encapsulated)
was fed in combination to rats. Intake and k i l l on the "combined" diet was again compared
with normal and encapsulated norbormide fed separately (Fig. XIII). Two phase ratios of
ethyl cellulose were investigated. In confirmation of the previous studies, the k i l l obtained with 1% norbormide not microencapsulated exceeded the mortality in all other treatments.
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Fig. X I I I . Intake (g/rat) and k i l l obtained with diets containing normal
and microencapsulated norbormide (ethyl cellulose 8:1 and 20:1)
fed at various concentrations, separately and in combination to
rats (20 per treatment) for 2 days.
DISCUSSION
Careful use of warfarin against susceptible populations of w i l d Rattus norvegicus and Mus
musculus can provide 100% control, but the efficiency of acute rodenticides varies between 5090%, depending on the known extent of the rodent population, location of harbourages,
a v a i l a b i l i t y of alternative food, s k i l l in application, and the use of prebaiting. This
generalisation serves to illustrate the need to be met by microencapsulation: that it should
improve the efficacy of rodenticides above that already experienced in f i e l d use, to give
mortalities of 90-100%. Most of the laboratory tests reported here were designed to explore
t h i s area of improvement.
The studies of Greaves et al. (1968), which showed improved k i l l with norbormide (encapsulated in gelatin at 4:1) and alphachloralose (encapsulated in ethyl cellulose at 10:1), were
not only conducted with very small numbers of animals, but in case was the k i l l obtained with
the unencapsulated rodenti c i d e above 50%. Thus, summing over the concentrations tested by
these workers, encapsulation of norbormide increased ki11 from 24% to 52% and encapsulation of
alphachloralose increased k i l l from 20% to 45%. Some of our tests have shown s i m i l a r
improvements, when mortality of the animals fed unencapsulated rodenticide is very low.
As a corollary, it is relevant to emphasise that in the l i m i t e d tests of Greaves et a1.,
k i l l s of 80-100% obtained with normal alphachloralose, administered o r a l l y at high doses, were
lowered when the poison was encapsulated.
From presently available information, it would appear, therefore, that with very low
"takes" of rodenticide, caused by bait shyness or other environmental factors leading to
reduced rodenti c i d a l action, microencapsulation may provide a marginal improvement in the
f i e l d . Where "takes" already result in 50-90% k i l l , encapsulation with the systems so far
explored offers l i t t l e advantage.
Microencapsulation can increase the intake of rodenticides considerably, low phase ratios
g i v i n g higher intakes than high ratios and gelatin walls being more readily digested than
w a l l s of ethyl cellulose. In some instances the intake of active ingredient has been increased by up to 10 times, even in the presence of alternative food, but it is clear that a
considerable proportion of the additional poison ingested is unavailable or physiologically
inactive.
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It is possible to postulate a number of reasons for failure to obtain improved
kill:
1. Capsule wall not digested. The capsule wall is not digested sufficiently rapidly
to
allow absorption of active ingredient through the epithelial l i n i n g at the
appropriate stage
in the gut. Unhardened gelatin capsules are possibly less resistant to digestion
than
hardened walls.
2. Limited absorption. The high rate of action of both alphachloralose and
norbormide is
a clear indication that considerable absorption occurs in the stomach. There may be
an
upper l i m i t to the rate at which these drugs w i l l diffuse across the gastric mucosa
and
beyond t h i s l i m i t any increase in concentration of drug w i l l not affect the rate of
absorption by the blood. This being so, the encapsulation of rodenticides as l i q u i d s
would not
improve matters even if solvents compatible with encapsulation and palatability could
be
found.
3. I n h i b i ted metabolic action. The amount of rodenticide released may i n h i b i t
metabolic
action (interfering possibly with enzyme activity and movement of food through the
gut) and
thus prevent the absorption of the greater proportion of rodenticide remaining in the
capsules. This could certainly apply to alphachloralose which induces hypothermia.
Crystals
of t h i s rodenticide are not conducive to uniform coating, and release from p a r t i a l l y
coated
crystals may be sufficient to cause m i l d symptoms preventing the release w i t h i n the
stomach
of the bulk of encapsulated rodenticide.
A. Detoxification. With active ingredients released slowly through the capsule
wall the rodent may be able to metabolise the rodenticide as it is released. This
could apply to alphachloralose and norbormide.
FUTURE STUDIES
Any one, or a number of the above factors, alone or in combination, could
preclude the advantage gained by getting a high concentration of rodenticide into
the gut through improved palatabi1ity, or delayed onset of poisoning symptoms.
Conditions in the gut which result in the "explosive release" of the internal phase
from the capsules may help to improve rodenti c i d a l action, but t h i s may not be
readily achieved. Improvements which have been made in the action of pharmaceutical
preparations come from extending release, and therefore physiological action of
drugs, taken acutely. With rodenticides, the requirement would appear to be the
reverse: intake of the poison may be spread over minutes or hours and the objective
of encapsulation would appear to be timed explosive release, to achieve a high
"instantaneous" liberation of internal phase to bring about maximum physiological
action.
The studies now being undertaken include the incorporation of enzymes in the
encapsulated diets to assist in removal of the gelatin w a l l s . These and other methods
are f i r s t being investigated under the microscope in simulated gut f l u i d s before
the feeding studies are extended.
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